A study to evaluate the effect of Lactobites bar as a galactagogue to increase the production of milk in lactating women and promote overall healthy recovery of lactating mothers

Breastfeeding is widely acknowledged as the preferred and recommended mode of infant nutrition. However, women who have undergone cesarean deliveries may face an increased risk of inadequate breast milk production, which can be addressed through various techniques, including the use of galactagogues, which stimulate breast milk production. Galactagogues are synthetic or plant molecules that induce, maintain, and increase milk production.In this current real-world evidence study, 53 lactating women were enrolled. During the study, they received lactobites bar for 28 days. The intestinal health of the baby, incidences of formula feeding, the volume of breast milk, baby's anthropometric measures: such as changes in height, changes in the quality of hair and skin of the mother were evaluated. The feeling of wellness in the mother and haemoglobin levels were also assessed during the study.The haemoglobin levels were significantly increased in mothers who were given lactobites bar. A significant increase was observed in hours of night and day sleep, stool frequency per day, vol. of breast milk [baseline vs 28 day: 30.19 ± 34.4 vs 448.06 ± 651.11; P<0.05], no. of diapers per day, height [baseline vs 28th day: 47.39±1.72 vs 50.1±1.62; P<0.05], changes in quality of hair and skin of mother, and the feeling of wellness in mother [baseline vs 28th day: 0.04 ± 0.19 vs 1.88 ± 0.32; P<0.05]. A significant reduction was observed in formula feeding incidence (<0.001). No side effects were reported. Lactobites bar can be used as a galactagogue to increase the human milk volume in lactating women.